Heart rate and the cardiovascular risk

Journal of Hypertension

Volumn 15, Issue 1, 1997, Pages 3-17

  Palatini, Paolo ^b   Julius, Stevo ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF PADOVA   (Italy)

Author keywords

Ambulatory blood pressure; Cardiovascular risk; Heart rate; Home blood pressure; Hypertension; Insulin resistance; Mortality; Sympathetic nervous system; Whitecoat hypertension

Indexed keywords

ADRENERGIC SYSTEM; BLOOD PRESSURE; CARDIOVASCULAR RISK; FEMALE; HEART RATE; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MALE; MORTALITY; PREDICTION; PRIORITY JOURNAL; REVIEW; SEX DIFFERENCE; TACHYCARDIA;

EID: 0031053156     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-199715010-00001     Document Type: Review

References (139)

1. Julius S, Krause L, Schork N, Mejia A, Jones K, Van de Ven C, et al.: Hyperkinetic borderline hypertension in Tecumseh, Michigan. J Hypertens 1991, 9:77-84.
2. Julius S, Jamerson K, Mejia A, Krause L, Schork N, Jones K: The association of borderline hypertension with target organ changes and higher coronary risk. Tecumseh Blood Pressure Study. JAMA 1990, 264:354-358.
3. Palatini P, Pessina AC, Dal Palu̇ C: The Hypertension and Ambulatory Recording Venetia Study (HARVEST): a trial on the predictive value of ambulatory blood pressure monitoring for the development of fixed hypertension in patients with borderline hypertension. High Blood Press 1993, 2:11-18.
4. Palatini P, Mormino P, Canali C, Santonastaso M, De Venuto G, Zanata G, et al.: Factors affecting ambulatory blood pressure reproducibility. Results of the HARVEST Study. Hypertension 1994, 23:211-216.
5. Palatini P, Graniero G, Mormino P, Nicolosi L, Mos L, Visentin P: Relation between physical training and ambulatory blood pressure in stage I hypertensive subjects. Results of the HARVEST Trial. Circulation 1994, 90:2870-2876.
6. Casiglia E, Zamboni S, Mormino P, Ambrosio GB, Dal Palu, C: Hypertension, glycemia and blood lipids in a general population. Eur Heart J 1989, 10 (suppl 3):815-820.
7. Casiglia E, d'Este D, Ginocchio G, Colangeli G, Onesto C, Tramontin P, et al.: Lack of influence of menopause on blood pressure and cardiovascular risk profile: a 16-year longitudinal study concerning a cohort of 568 women. J Hypertens 1996, 14:729-736.
8. Staessen JA, Fagard R, Amery A: Life style as a determinant of blood pressure in the general population. Am J Hypertens 1994, 7:685-694.
9. Staessen JA, Bieniaszewski L, OBrien ET, Imai Y, Fagard RM: Epidemiologic approach to ambulatory blood pressure monitoring: the Belgian Population Study. Blood Pressure Monitoring 1996, 1:13-26.
10. Staessen JA, Roels H, Fagard R and for the PheeCad Investigators: Lead exposure and conventional and ambulatory blood pressure. JAMA 1996, 275:1563-1570.
11. Pauletto P, Puato M, Caroli MG, Casiglia E, Munhambo AE, Cazzolato G: Lower blood pressure and atherogenic lipoprotein levels in a population living on a freshwater fish diet versus a population living on a vegetarian diet in Tanzania. The Lugarawa Study. Lancet 1996, ii:784-788.
12. Julius S: Transition from high cardiac output to elevated vascular resistance in hypertension. Am Heart J 1988, 116:600-606.
13. Stamler J, Berkson DM, Dyer A, Lepper MH, Lindberg HA, Paul O, et al.: Relationship of multiple variables to blood pressure - findings from four Chicago epidemiologic studies. In Epidemiology and Control of Hypertension. Edited by Paul O. Miami: Symposia Specialists; 1975:307-352.
14. Erikssen J, Rodahl K: Resting heart rate in apparently healthy middle-aged men. Eur J Appl Physiol 1979 42:61-69.
15. Berenson GS, Voors AW, Webber LS, Dalferes ER Jr, Harsha DW: Racial differences of parameters associated with blood pressure levels in children. The Bogalusa Heart Study. Metabolism 1979, 28:2218-1228.
16. Schieken RM, Clarke WR, Lauer RM: Left ventricular hypertrophy in children with blood pressures in the upper quintile of the distribution The Muscatine study. Hypertension 1981, 3:669-675.
17. Simpson FO, Waal-Manning HJ, Boli P, Spears GFS: The Milton survey 2. Blood pressure and heart rate. NZ Med J 1978, 88:1-4.
18. Schroll M, Hagerup LM: Risk factors of myocardial infarction and death in men aged 50 at entry. A ten-year prospective study from the Glostrup population studies. Dan Med Bull 1977, 24:252-255.
19. Reed D, McGee D, Yano K: Biological and social correlates of blood pressure among Japanese men in Hawaii. Hypertension 1982, 4:406-414.
20. Levy RL, White PD, Stroud WD, Hillman CC: Transient tachycardia: prognostic significance alone and in association with transient hypertension. JAMA 1945, 129:585-588.
21. Medalie JH, Kahn RA, Neufeld HN, Riss E, Goldbourt U: Five-year myocardial infarction incidence. II. Association of single variables to age and birthplace. J Chron Dis 1973, 26:329-349.
22. Filipovsky J, Ducimetiere P, Safar ME: Prognostic significance of exercise blood pressure and heart rate in middle-aged men. Hypertension 1992, 20:333-339.
23. Kannel WB, Sorlie P: Hypertension in Framingham. In Epidemiology and Control of Hypertension. Edited by Paul O. New York: Stratton; 1975:553-592.
24. Cirillo M, Laurenzi M, Trevisan M, Stamler J: Hematocrit blood pressure, and hypertension. The Gubbio Population Study. Hypertension 1992, 20:319-326.
25. Alexander F: A medical survey of the Aleutian Islands. N Engl J Med 1949, 240:1035-1039.
26. Padmayati S, Gupta S: Blood pressure studies in rural and urban groups in Delhi. Circulation 1959, 19:393-398.
27. Kaufman JS, Durazo-Arivizu RA, Rotimi CN, McGee DL, Cooper RS: Obesity and hypertension prevalence in populations of African origin. Epidemiology 1996, 7:398-405.
28. Cooper R, Rotimi C, Ataman S, McGee D, Osotimehin B, Kadiri S, et al.: Prevalence of hypertension in seven populations of African origin. Am Public Health 1996, in press.
29. Messerli FH, Frohlich ED, Suarez DH, Reisin E, Dreslinski GR, Dunn FG, et al.: Borderline hypertension: relationship between age, hemodynamics and circulating catecholamines. Circulation 1981, 64:760-764.
30. Safar ME, Weiss YA, Levenson JA, London GM, Milliez PL: Hemodynamic study of 85 patients with borderline hypertension. Am J Cardiol 1973, 31:315-319.
31. Julius S, Schork MA: Borderline hypertension - a critical review. J Chron Dis 1971, 23:723-754.
32. Lund-Johansen P: Hemodynamics in early essential hypertension. Acta Med Scand 1967, 482 (suppl):1-105.
33. Sannerstedt R: Hemodynamic response to exercise in patients with arterial hypertension. Acta Med Scand 1966, 458 (suppl):1-83.
34. Julius S, Conway J: Hemodynamic studies in patients with borderline blood pressure elevation. Circulation 1968, 38:282-288.
35. Widimski J, Fejfarova MH, Fejfar Z: Changes of cardiac output in hypertensive disease. Cardiologia 1957, 31:381-389.
36. Eich RH, Cuddy RP, Smulyan H, Lyons RH: Hemodynamics in labile hypertension: a follow-up study. Circulation 1966, 34:299-307.
37. Frohlich ED, Kozul VJ, Tarazi RC, Dustan HP: Physiological comparison of labile and essential hypertension. Circ Res 1970, 26 (suppl 1):55-69.
38. Palatini P, Bongiovi S, Mario L, Schiraldi C, Mos L, Pessina AC: Supernormal left ventricular performance is present during exercise in young subjects with mild hypertension. Eur Heart J 1995, 16:232-242.
39. Palatini P, Visentin PA, Nicolosi G, Nione V, Stritoni P, Canali C: Supernormal left ventricular performance in young subjects with mild hypertension. An alerting response to the echocardiographic procedure? Clin Sci 1996 91:275-281.
40. Birkenhager WH: Presidential lecture. A critical interpretation of juvenile borderline hypertension. J Hypertens 1991, 9 (suppl 6): S2-S9.
41. Mo R, Nordrehaug J, Omvik P, Lund-Johansen P: The Bergen blood pressure study: prehypertensive changes in cardiac structure and function in offspring of hypertensive families. Blood Pressure 1995, 4:16-22.
42. Thomas CB, Ross DC, Higgenbottom CQ: Precursors of hypertension and coronary disease among healthy medical students. Discriminant function analysis. II. Using parental history as the criterion. Bull Johns Hopkins Hosp 1994, 115:245-264.
43. Kahn HA, Medalie JH, Neufeld HN: The incidence of hypertension and associated factors: the Israel ischemic heart disease study. Am Heart J 1972, 84:171-182.
44. Thomas J, Semenya KA, Neser WB: Risk factors and the incidence of hypertension in black physicians. Am Heart J 1985, 110:637-645.
45. Selby JV, Friedman GD, Quesenberry CP Jr: Precursors of essential hypertension: pulmonary function, heart rate, uric acid, serum cholesterol, and other serum chemistries. Am J Epidemiol 1990, 131:1017-1027.
46. Garrison RJ, Kannel WB, Stokes J III: Incidence and precursors of hypertension in young adults. Prev Med 1987, 16:235-251.
47. Paffenbarger RS Jr, Thorne MC, Wing AL: Chronic disease in former college students. VIII. Characteristics in youth predisposing to hypertension in later years. Am J Epidemiol 1968, 88:25-32.
48. Sasakawa O, Fujii S, Nogi O, Shimura M, Tsumura K, Seki J: A study of long- term observations in borderline hypertension. Jpn Circ J 1983, 47:300-308.
49. Paul O, Lepper MH, Phelan WH: A longitudinal study of coronary heart disease. Circulation 1963, 28:20-30.
50. Morris JH, Gardner JM: Epidemiology of ischemic heart disease. Am J Med 1969, 46:674-684.
51. Dyer AR, Persky V, Stamler J, Paul O, Shekelle RB, Berkson DM, et al.: Heart rate as a prognostic factor for coronary heart disease and mortality: findings in three Chicago epidemiologic studies. Am J Epidemiol 1980, 112:736-749.
52. Gillum RF, Makuc DM, Feldman JJ: Pulse rate, coronary heart disease, and death: The NHANES I epidemiologic follow-up study. Am Heart J 1991, 121:172-177.
53. Kannel WB, Wilson P, Blair SN: Epidemiologic assessment of the role of physical activity and fitness in development of cardiovascular disease. Am Heart J 1985, 109:876-885.
54. Kannel WB, Kannel C, Paffenbarger RS Jr, Cupples LA: Heart rate and cardiovascular mortality: The Framingham Study. Am Heart J 1987, 113:1489-1494.
55. Tibblin G, Wilhelmsen L, Werko L: Risk factors for myocardial infarction and death due to ischemic heart disease and other causes. Am J Cardiol 1975, 35:514-522.
56. Keys A, Taylor HL, Blackburn H: Mortality and coronary heart disease among men studied for 23 years. Arch Intern Med 1971, 128:201-214.
57. Goldberg RJ, Burchfiel CM, Benfante R, Chiu D, Reed DM, Yano K: Lifestyle and biologic factors associated with atherosclerotic disease in middle-aged men. 20-Year findings from the Honolulu Heart Program. Arch Intern Med 1995, 155:686-694.
58. Paffenbarger RS Jr, Wolf PA, Notkin J, Thorne MC: Chronic disease in former college students. Early precursors of fatal coronary heart disease. Am J Epidemiol 1966, 83:314-328.
59. Singer RB, Levinson L: Medical Risks: Patterns of Mortality and Survival. Lexington: D.C. Health and Company; 1976:128-129.
60. Goldberg RJ, Larson M, Levy D: Factors associated with survival to 75 years of age in middle-aged men and women. The Framingham study. Arch Intern Med 1996, 156:505-509.
61. Persky V, Dyer AR, Leonas J, Stamler J, Berkson DM, Lindberg HA: Heart rate: a risk factor for cancer? Am J Epidemiol 1981, 114:477-487.
62. Garcia-Palmieri MR, Sorlie PD, Costas R: An apparent inverse relationship between serum cholesterol and cancer mortality in Puerto Rico [abstract]. CVD Epidemiol Newsletter 1980, 28:22.
63. Morton NE: The detection of major genes under additive continuous variation. Am J Hum Genet 1967, 19:23-24.
64. Littler WA: Sleep and blood pressure: further observations. Am Heart J 1979, 97:35-37.
65. Palatini P, Penzo M, Racioppa A, Zugno E, Gizzardi G, Anaclerio M: Clinical relevance of nighttime blood pressure and of daytime blood pressure variability. Arch Intern Med 1992, 152:1855-1860.
66. Millar-Craig MW, Bisop CN, Raftery EB: Circadian variation in blood pressure. Lancet 1978, i:795-797.
67. Mancia G, Ferrari A, Gregorini L, Paratt G, Pomidossi G, Bertinieri G, et al.: Blood pressure and heart rate variabilities in normotensive and hypertensive human beings. Circ Res 1983, 53:96-104.
68. Casiglia E, Palatini P, Colangeli G, Ginocchio G, DiMenza G, Onesto C, et al.: 24 H rhythm of blood pressure and forearm peripheral resistance in normotensive and hypertensive subjects confined to bed. J Hypertens 1996, 14:47-52.
69. Grimby G, Bjure J, Aurell M, Ekstrom-Jodal B, Tibblin G, Wilhelmsen G: Work capacity and physiological responses to work. Men born in 1913. Am J Cardiol 1972, 30:37-42.
70. Cooper KH, Pollock ML, Martin RP, White SR, Linnerud AC, Jackson A: Physical fitness levels vs selected coronary risk factors. A cross-sectional study. JAMA 1976, 236:116-169.
71. Beckman M, Panifilow V, Sivertsson R, Sannerstedt R, Andersson O: Blood pressure and heart rate recordings at home and at the clinic. Acta Med Scand 1981, 210:97-102.
72. Astrand P-O, Rodahl K: Physical training. In Textbook of Work Physiology. Physiological Bases of Exercise. Edited by Astrand P-O, Rodahl K. New York: McGraw-Hill; 1986:412-485.
73. Mancia G, Bertinieri G, Grassi G, Parati G, Pomidossi G, Ferrari A, et al.: Effects of blood pressure measurement by the doctor on patients blood pressure and heart rate. Lancet 1983, ii:695-697.
74. Schork NJ, Weder AB, Schork MA, Bassett DR, Julius S: Disease entities, mixed multi-normal distributions, and the role of the hyperkinetic state in the pathogenesis of hypertension. Statist Med 1990, 9:301-314.
75. Julius S, Schork N, Schork A: Sympathetic hyperactivity in early stages of hypertension: the Ann Arbor data set. J Cardiovasc Pharmacol 1988, 12 (suppl 3):5121-5129.
76. Seals DR, Hagberg JM: The effect of exercise training on human hypertension: a review. Med Sci Sports Exercise 1984, 16: 207-215.
77. Kingwell BA, Jennings GL: Effects of walking and other exercise programs upon blood pressure in normal subjects. Med J Aust 1993, 158:234-238.
78. Blair SN, Goodyear NN, Gibbons LW, Copper KH: Physical fitness and incidence of hypertension in healthy normotensive men and women. JAMA 1984, 252:487-490.
79. Paffenbarger RS Jr, Jung DL, Leung RW, Hyde RT: Physical activity and hypertension: an epidemiological review. Ann Intern Med 1991, 23:319-327.
80. Stern MP, Morales PA, Haffner SM, Valdez RA: Hyperdynamic circulation and the insulin resistance syndrome (syndrome X). Hypertension 1992, 20:802-808.
81. Mancia G, Parati G, Pomidossi G, Grassi G, Cagodei R, Zanchetti A: Alerting reaction and rise in blood pressure during measurement by physician and nurse. Hypertension 1987, 9:209-215.
82. Feskens EJM, Kromhout D: Hyperinsulinemia. risk factors, and coronary heart disease. Arterioscler Thromb 1994, 14:1641-1647.
83. Jose AD, Taylor RR: Autonomic blockade by propranolol and atropine to study intrinsic myocardial function in man. J Clin Invest 1969, 48:2019-2024.
84. Julius S, Pascual AV, London R: Role of parasympathetic inhibition in the hyperkinetic type of borderline hypertension. Circulation 1971, 44:413-418.
85. Frohlich ED, Tarazi RC, Dustan HP: Hyperdynamic beta-adrenergic circulatory state: increased beta-receptor responsiveness. Arch Intern Med 1969, 123:1-7.
86. Julius S, Randall OS, Esler MD, Kashima T, Ellis CN, Bennett J: Altered cardiac responsiveness and regulation in the normal cardiac output type of borderline hypertension. Circ Res 1975, 36-37 (suppl I):I199-I207.
87. Trimarco B, Volpe M, Ricciardelli B, Picotti GB, Galva MA, Petracca R, et al.: Studies of the mechanisms underlying impairment of beta-adrenoceptor-mediated effects in human hypertension. Hypertension 1983, 5:584-590.
88. Esler M, Julius S, Randall O, DeQuattro V, Zweifler A: High-renin essential hypertension: adrenergic cardiovascular correlates. Clin Sci Mol Med 1976, 51:181s-184s.
89. Julius S: Interaction between renin and the autonomic nervous system in hypertension. Am Heart J 1988, 116:611-616.
90. Bohm R, van Baak M, van Hooff M, Moy J, Rahn KH: Salivary flow in borderline hypertension. Klin Wochenschr 1985, 63 (suppl 3): 154-156.
91. Guzzetti S, Piccaluga E, Casati R, Cerutti S, Lombardi F, Pagani M, et al.: Sympathetic predominance in essential hypertension: a study employing spectral analysis of heart rate variability. J Hypertens 1988, 6:711-717.
92. Parati G, Philip SJ, DiRienzo M, Mancia G: Spectral analysis of blood pressure and heart rate variability in evaluating cardiovascular regulation. A critical appraisal. Hypertension 1995, 25:1276-1286.
93. Polonsky KS, Given BO, Van Cauter E: 24-hour profile and pulsatile pattern of insulin secretion in normal and obese subjects. J Clin Invest 1988, 81:442-448.
94. DeFronzo RA, Ferrannini E: Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 1991, 14:173-194.
95. Julius S: Sympathetic hyperactivity and coronary risk in hypertension. Corcoran lecture. Hypertension 1993, 21:886-893.
96. Deibert DC, DeFronzo RA: Epinephrine-induced insulin resistance in man. J Clin Invest 1980, 65:717-721.
97. Zeman RJ, Ludemann R, Easton TG, Etlinger JD: Slow to fast alterations in skeletal muscle fibers caused by clenbuterol, a beta-2-receptor agonist. Am J Physiol 1988, 254:E726-E732.
98. Jamerson KA, Julius S, Gudbrandsson T, Andersson O, Brant DO: Reflex sympathetic activation induces acute insulin resistance in the human forearm. Hypertension 1993, 21:618-623.
99. Jamerson KA, Smith SD, Amerena JV, Grant E, Julius S: Vasoconstriction with norepinephrine causes less forearm insulin resistance than a reflex sympathetic vasoconstriction. Hypertension 1994, 23:1006-1011.
100. Pyorala K, Savolainen E, Kaukola S, Haapakoski J: Plasma insulin as a coronary heart disease risk factor: relationship to other risk factors and predictive value during 9 1/2 year follow-up of the Helsinki Policemen Study population. Acta Med Scand Suppl 1985, 701: 38-52.
101. Reaven GM: Banting lecture 1988; role of insulin resistance in human disease. Diabetes 1988, 37:1595-1607.
102. Kissebah AH, Adams PW, Wynn V: Inter-relationship between insulin secretion and plasma free fatty acid and triglyceride transport kinetics in maturity on set diabetes and the effect of phenethylbiguanide (Phenformin). Diabetologia 1974, 10:119-130.
103. Taskinen MR: Lipoprotein lipase in diabetes. Diabetes Metab Rev 1987, 3:551-570.
104. Orchard TJ, Becker DJ, Bates M: Plasma insulin and lipoprotein cholesterol concentrations: an atherogenic association? Am J Epidemiol 1983, 118:326-337.
105. Sorlie PD, Garcia-Palmieri MR, Costas R Jr, Havlik RJ: Hematocrit and risk of coronary heart disease: the Puerto Rico Heart Health Program. Am Heart J 1981, 101:456-461.
106. Salonen JT, Nyyssonen K, Korpela H, Tuomilehto J, Seppanen R, Salonen R: High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men. Circulation 1992, 86:803-811.
107. Tarazo RC, Frohlich ED, Dustan HP: Plasma volume in men with essential hypertension. N Engl J Med 1968, 278:762-765.
108. Julius S, Pascual A, Reilly K, London R: Abnormalities of plasma volume in borderline hypertension. Arch Intern Med 1971, 127:116-119.
109. Cohn JN: Relationship of plasma volume changes to resistance and capacitance vessel effects of sympathomimetic amines and angiotensin in man. Clin Sci 1966, 30:267-278.
110. Julius S, Pascual AV, Abbrecht PH, London R: Effect of beta-adrenergic blockade on plasma volume in human subjects. Proc Soc Exp Biol Med 1972, 140:982-985.
111. Landsberg L, Krieger DR: Obesity, metabolism, and the sympathetic nervous system. Am J Hypertens 1989, 2:125s-132s.
112. Gordon D, Guyton I, Karnovsky N: Intimai alterations in rat aorta induced by stressful stimuli. Lab Invest 1983, 45:14-19.
113. Hirsch EZ, Maksem JA, Gagen D: Effects of stress and propranolol on the aortic intima of rats [abstract]. Arteriosclerosis 1984, 4:526.
114. Kaplan JR, Manuck SB, Adams MR, Weingand KW, Clarkson TB: Inhibition of coronary atherosclerosis by propranolol in behaviorally predisposed monkeys fed an atherogenic diet Circulation 1987, 76:1364-1372.
115. Beere PA, Glagov S, Zarins CK: Retarding effect of lowered heart rate on coronary atherosclerosis. Science 1984, 226:180-182.
116. Lown B, Verrier RL: Neural activity and ventricular fibrillation. N Engl J Med 1976, 294:1165.
117. Schwartz PJ, LaRovere MT, Vanoli E: Autonomic nervous system and sudden death. Circulation 1992, 1 (suppl I):77-91.
118. Lown B: Sudden cardiac death: the major challenge confronting contemporary cardiology. Am J Cardiol 1979, 43:313-328.
119. Schwartz PJ, Priori SG: Sympathetic nervous system and cardiac arrhythmias. In Cardiac Electrophysiology: From Cell to Bedside. Edited by Zipes DP, Jalife J. Philadelphia: W.B. Saunders Co.; 1990:330-343.
120. Hohlnoser SH, Klingenheben T, van de Loo A, Hablawetz B, Just H, Schwartz PJ: Reflex versus tonic vagal activity as a prognostic parameter in patients with sustained ventricular tachycardia or ventricular fibrillation. Circulation 1994, 89:1068-1073.
121. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP: Prognostic implications of echocardiographically determined left ventricular mass in the Framingham heart study. N Engl J Med 1990, 322:1561-1566.
122. Simpson P: Norepinephrine-stimulated hypertrophy of cultured rat myocardial cells is an alpha-1 adrenergic response. J Clin Invest 1983, 72:732-738.
123. Man MN, Heistad DD, Brody MJ: Effect of chronic hypertension and sympathetic denervation on wall/lumen ratio of cerebral vessels. Hypertension 1980, 2:419-428.
124. Bevan RD, Tsuru H, Bevan JH: Cerebral artery mass in the rabbit is reduced by chronic sympathetic denervation. Stroke 1983, 14:393-396.
125. Laks MM, Morady F, Swan HJC: Myocardial hypertrophy produced by chronic infusion of subhypertensive doses of norepinephrine in the dog. Chest 1973, 64:75-78.
126. Julius S, Li Y, Brant D, Krause L, Buda A: Neurogenic presser episodes fall to cause hypertension, but do induce cardiac hypertrophy. Hypertension 1989, 13:422-429.
127. Hartford M, Wikstrand J, Wallentin I, Ljungman S, Wilhelmsen L, Berglund G: Left ventricular mass in middle-aged men. Relationship to blood pressure, sympathetic nervous activity, hormonal and metabolic factors. Clin Exp Hypertens [A] 1983, 5:1429-1451.
128. Ferrara LA, Moscato TS, Pisanti N, Marotta T, Krogh V, Capone D, et al.: Is the sympathetic nervous system altered in children with familial history of arterial hypertension? Cardiology 1988, 75:200-205.
129. Marcus R, Krause L, Weder AB, Mejia AD, Schork NJ, Julius S: Sex-specific determinants of increased left ventricular mass in the Tecumseh blood pressure study. Circulation 1994, 90:928-936.
130. Paffenbarger RS Jr, Hyde RT, Wing AL, Hsieh CC: Physical activity, all-cause mortality, and longevity of college alumni. N Engl J Med 1986, 314:605-613.
131. Smoking and Health - A Report of The Surgeon General. Washington DC: DHEW; 1979.
132. Pell S, DAlonso C: A five-year mortality study of alcoholics. J Intern Med 1973, 15:120-125.
133. Dyer AR, Stamler J, Paul O: Alcohol consumption and 17-year mortality in the Chicago Western Electric Company Study. Prev Med 1980, 9:78-90.
134. Schmidt W, DeLint J: Causes of death of alcoholics. Quart J Stud Alcohol 1972, 33:171-1850.
135. LaBarba RC: Experimental and environmental factors in cancer. A review of research with animals. Psychosom Med 1970, 32:259-276.
136. Hurst MW, Jenkins CD, Rose RM: The relation of psychological stress to onset of medical illness. Annu Rev Med 1976, 27:301-312.
137. Watson CG, Sculd D: Psychosomatic factors in the etiology of neoplasms. J Consult Clin 1976, 45:455-461.
138. LeShan L: Psychological states as factors in the development of malignant disease. A critical review. J Clin Invest 1959, 22:1-18.
139. Burchfiel CM, Curb JD, Sharp DS, Rodriguez BL, Arakaki R: Distribution and correlates of insulin in elderly men. The Honolulu Heart Program. Arterioscler Thromb 1995, 15:2213-2221.